TY - JOUR
T1 - Variable expressivity of the beckwith-wiedemann syndrome in four pedigrees segregating loss-of-function variants of cdkn1c
AU - Sparago, Angela
AU - Cerrato, Flavia
AU - Pignata, Laura
AU - Cammarata-Scalisi, Francisco
AU - Garavelli, Livia
AU - Piscopo, Carmelo
AU - Vancini, Alessandra
AU - Riccio, Andrea
N1 - Funding Information:
This research was funded by: Associazione Italiana Ricerca sul Cancro IG 2020 N.24405 (AR); Telethon-Italia GGP15131 (AR); ?Progetti per la ricerca oncologica della Regione Campania? Grant: I-Cure (AR and FC); ?Progetti competitivi intraAteneo? Programma V:ALERE (VAnviteLli pEr la RicErca) 2019?grant MIRIAM from Universit? degli Studi della Campania ?Luigi Van-vitelli? (AR, FC and AS); European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA EU Framework Partnership Agreement ID: 3HP-HP-FPA ERN-01-2016/739516 (LG). The authors are grateful to the patients and their family members and the Italian BWS patient support group AIBWS for their collaboration.
Funding Information:
Funding: This research was funded by: Associazione Italiana Ricerca sul Cancro IG 2020 N.24405 (AR); Telethon-Italia GGP15131 (AR); “Progetti per la ricerca oncologica della Regione Campania” Grant: I-Cure (AR and FC); “Progetti competitivi intraAteneo” Programma V:ALERE (VAnviteLli pEr la RicErca) 2019—grant MIRIAM from Università degli Studi della Campania “Luigi Van-vitelli” (AR, FC and AS); European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA EU Framework Partnership Agreement ID: 3HP-HP-FPA ERN-01-2016/739516 (LG).
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/5
Y1 - 2021/5
N2 - Beckwith-Wiedemann syndrome (BWS) is an imprinting disorder characterized by prenatal and/or postnatal overgrowth, organomegaly, abdominal wall defects and tumor predisposition. CDKN1C is a maternally expressed gene of the 11p15.5 chromosomal region and is regulated by the imprinting control region IC2. It negatively controls cellular proliferation, and its expression or activity are frequently reduced in BWS. In particular, loss of IC2 methylation is associated with CDKN1C silencing in the majority of sporadic BWS cases, and maternally inherited loss-of-function variants of CDKN1C are the most frequent molecular defects of familial BWS. We have identified, using Sanger sequencing, novel CDKN1C variants in three families with recurrent cases of BWS, and a previously reported variant in a woman with recurrent miscarriages with exomphalos. Clinical evaluation of the patients showed variable manifestation of the disease. The frameshift and nonsense variants were consistently associated with exomphalos, while the missense variant caused a less severe phenotype. Pregnancy loss and perinatal lethality were found in the families segregating nonsense mutations. Intrafamilial variability of the clinical BWS features was observed, even between siblings. Our data are indicative of severe BWS phenotypes that, with variable expressivity, may be associated with both frameshift and nonsense variants of CDKN1C.
AB - Beckwith-Wiedemann syndrome (BWS) is an imprinting disorder characterized by prenatal and/or postnatal overgrowth, organomegaly, abdominal wall defects and tumor predisposition. CDKN1C is a maternally expressed gene of the 11p15.5 chromosomal region and is regulated by the imprinting control region IC2. It negatively controls cellular proliferation, and its expression or activity are frequently reduced in BWS. In particular, loss of IC2 methylation is associated with CDKN1C silencing in the majority of sporadic BWS cases, and maternally inherited loss-of-function variants of CDKN1C are the most frequent molecular defects of familial BWS. We have identified, using Sanger sequencing, novel CDKN1C variants in three families with recurrent cases of BWS, and a previously reported variant in a woman with recurrent miscarriages with exomphalos. Clinical evaluation of the patients showed variable manifestation of the disease. The frameshift and nonsense variants were consistently associated with exomphalos, while the missense variant caused a less severe phenotype. Pregnancy loss and perinatal lethality were found in the families segregating nonsense mutations. Intrafamilial variability of the clinical BWS features was observed, even between siblings. Our data are indicative of severe BWS phenotypes that, with variable expressivity, may be associated with both frameshift and nonsense variants of CDKN1C.
KW - Beckwith-Wiedemann syndrome
KW - CDKN1C
KW - Exomphalos
KW - Genomic imprinting
KW - Loss-of-function mutations
UR - http://www.scopus.com/inward/record.url?scp=85106523625&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106523625&partnerID=8YFLogxK
U2 - 10.3390/genes12050706
DO - 10.3390/genes12050706
M3 - Article
C2 - 34065128
AN - SCOPUS:85106523625
SN - 2073-4425
VL - 12
JO - Genes
JF - Genes
IS - 5
M1 - 706
ER -